arrow
R

Rab K. Prinjha

GlaxoSmithKline
H指数:64
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differential BET protein recruitment to IL6 and IL8 promoters and suppression of inflammatory and cell cycle genes by BET inhibitor in keratinocytes

角化细胞中BET蛋白对IL6和IL8启动子的差异性募集以及BET抑制剂对炎症和细胞周期基因的抑制作用

2026-09-130
PRE
SUMOylation enhances DNMT1 function to repress mega-intergenic RNAs and viral mimicry
2026-07-210
PRE
NLRP3 inflammasome–driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors

NLRP3炎性小体驱动的噬血细胞性淋巴组织细胞增多症的发生与IL-1β和IL-18无关,且可被BET抑制剂靶向治疗。

2025-07-090
PREAI
Acute Resistance to BET Inhibitors Remodels Compensatory Transcriptional Programs Via p300 Co-Activation

急性对BET抑制剂的耐药性通过p300协同激活重塑补偿性转录程序

BLOOD
IF23.1
2024-11-050
PRE
Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787
2024-06-120
PRE
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells
2023-04-152
OAAI
Identification and Optimization of a Ligand-Efficient Benzoazepinone Bromodomain and Extra Terminal (BET) Family Acetyl-Lysine Mimetic into the Oral Candidate Quality Molecule I-BET432
2022-11-158
OA
A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn's Disease
CELLS
IF5.2
2022-09-123
OAAI